Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.27 EUR | +3.89% | +7.57% | +16.71% |
Apr. 16 | Pihlajalinna plc announces Changes in Management Team | CI |
Apr. 10 | Pihlajalinna plc Approves Dividend for the Year 2023, Payable on April 19, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.36 for the current year.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.75 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.71% | 192M | C+ | ||
-14.58% | 85.02B | B- | ||
+15.05% | 82.37B | C+ | ||
+10.49% | 29.29B | C+ | ||
-10.17% | 17.21B | B | ||
-0.43% | 16.7B | A- | ||
-31.05% | 11.8B | - | - | |
+2.40% | 12.15B | A- | ||
+31.86% | 12.12B | B- | ||
-2.37% | 12.13B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PIHLIS Stock
- Ratings Pihlajalinna Oyj